Start From Emergency Doctor

Chapter 168

This is a disease of wealth, and ordinary people have only one dead end.

In this regard, Haoyue was relatively lucky, at least able to afford the high treatment costs.

Zhou Yuan and He Jianyi breathed a sigh of relief after seeing the nurse hanging the stem cell suspension on the infusion stand and starting to inject Haoyue intravenously.

The two left the transplant cabin, ready to return to the emergency department.

Liu Huimin has also been sent to the general ward. During this time, she took leave and the hospital’s work was replaced by someone else.

He Jianyi looked at Zhou Yuan walking beside him, his heart was shocked.

“When did you learn bone marrow transplantation so well…”

This technique is not difficult, but, like stitching, being able to do it and achieving a high level are completely two concepts.

And Zhou Yuan’s bone marrow transplantation technique is much better than that of hematology and oncology doctors, which is obviously of a high level…

He Jianyi estimated that if the original survival rate was only 10%, and the chief surgeon of bone marrow transplantation was replaced by Zhou Yuan, the success rate might increase to 40%!

For individuals, although this number is high, it is not terrible. After all, there is still a 60% mortality rate.

But… if you look at the group of bone marrow transplant surgery, then 30% of the patients who are doomed to die will get a new birth!

“Zhou Yuan, how did you do it…” He Jianyi couldn’t help but ask.

Zhou Yuan: “Insight.”

He Jianyi laughed helplessly: “Since I don’t want to say it, I can only regard you as talented… Except for this, there is no other explanation. However, your talent is too scary!”

Zhou Yuan sighed.

It was really epiphany.

“You say yes, system?”

The system said perfunctorily: “Right, right, right.”

The two continued to walk forward. When they arrived at the lounge, He Jian stopped consciously, but Zhou Yuan continued to walk forward.

“Zhou Yuan, didn’t you rest in the lounge?”

Zhou Yuan straightened the badge on his chest and said, “Teacher, I am already a resident now.”

He Jian was taken aback, a little surprised.

The twenty-six-year-old resident…This is really scary.(Read more @ wuxiax.com)

“Let’s go, I’ll take you to see your office.”

With that said, He Jianyi led Zhou Yuan to the public office.

Zhou Yuan paused and said, “Teacher, my office is independent…”

He Jianyi; “Oh, independent…what?! Independent?!”

This time He Jianyi was really scared.

He worked hard in this emergency department for 20 or 30 years, and finally got promoted to the deputy chief physician, and then he had an office. Zhou Yuan only came to the hospital for more than a month…

Zhou Yuan smiled and nodded, and took He Jianyi to his new office.

The office is not big, just about the size of the dean’s office.

He Jianyi was already a little dumbfounded, “Dean Fang takes you too seriously.”

However, this is not incomprehensible.

At the level of Zhou Yuan’s surgery, having an independent office is not incredible.

“Teacher, how are you doing with the new thrombolytic drug?”

Zhou Yuan opened the door of his office and invited He Jianyi in.

He Jianyi sat down and said with some worry: “Do you know Zhao Lei, Director Zhao of the personnel department of the hospital? Zhao Lei is a classmate of Liu Huimin and I at university. She is the director of the personnel department, better than me. Liu Huimin is one level older.”

“Zhao Lei’s husband is the general manager of Huiwei Pharmaceutical Group. It can be said that he is the person in charge of Huiwei Pharmaceutical Group. He is called Fang Zhijun. He bought my ex-wife Mei Lan and asked me to sign.”

“Fang Zhijun thought I would sign on the face of Mei Lan as my ex-wife. It’s so naive…I will never help Huiwei Pharmaceutical Group to cover up the ugly truth!”

Zhou Yuan nodded, and then asked, “How is the progress of the Drug Administration?”

It is impossible to expose and report the new thrombolytic drug of Huiwei Pharmaceutical Group to the Food and Drug Administration. This new drug is backed by billions of dollars in profits. Such a lucrative return is enough to clear all obstacles on the way to market.

“It is still under review. I estimate that this new type of thrombolytic drug will appear on the market in at most three months, and the drug price is estimated to be between several thousand and ten thousand.”

Of course, those doctors who agree to amend the signature on the expert certificate may be much cheaper, and it is estimated that it can be won by about 1,000.

This is an extremely attractive condition. A box of medicine is five to six thousand, seven to eight thousand cheaper. According to the hospital’s patient flow, the number of medicines is extremely scary…

“There is indeed a big temptation.” Zhou Yuan sighed.

The cost of medicine is not worth so much money, at most a few hundred yuan, but once a medicine is made, it is sparse and common for the price to increase several times or even dozens of times.

Because researching a new drug is time-consuming and costly, the research cycle is long, and the investment is extremely huge.

Take Gleevec, who can treat chronic myelogenous leukemia that Haoyue suffers from.

Before the advent of Gleevec, humans were almost at a loss for chronic myelogenous leukemia. Apart from waiting for a bone marrow transplant or suffering from the painful interference of chemotherapy, there was only a dead end.

However, the Swiss Novartis company spent fifty years, a large number of experts have devoted their lives to the study of Gleevec. Finally, after spending more than 5 billion US dollars, Gleevec was born.

This medicine turns chronic myelogenous leukemia, which can only wait for death, into a disease that can be controlled with drugs like hypertension and diabetes. As long as Gleevec is taken, patients with chronic myelogenous leukemia can live like ordinary people.

Therefore, those who have not been able to wait for a bone marrow transplant can use Gleevec to extend their lives.

But… a box of Gleevec can cost as much as 25,000 RMB!

It is also a life-saving medicine that needs to be taken for a long time, so ordinary people simply can’t afford it.

Say it is expensive and outrageous?

However, the manufacture and development of Gleevec cost countless experts behind the scenes. For 50 years, countless expert teams have been working day and night to tackle tough problems and paid more than 5 billion U.S. dollars…

If the price of medicines is not high, how can these costs be recovered?

Pharmaceutical companies are not charities, and experts are not saints. Without the drive of profit, no one will spend energy on researching new drugs. Without new drugs, the victims will be patients waiting for new drugs.

These pharmaceutical companies are like buying a lottery ticket. If they are developed, they will make a lot of money, but if they have not made progress after decades of research, it means that all their investment has been lost.

Back to Huiwei Pharmaceutical Group, the same is true.

To develop a new type of thrombolysis, Huiwei Pharmaceutical Group invested a large number of experts and spent more than one billion yuan.

If the drug is successfully listed, Huiwei Pharmaceutical Group can obtain billions of profits. However, if the new type of thrombolytic thrombolysis finally fails and is stopped by the Food and Drug Administration, they will suffer a loss of more than one billion yuan, which is not a large group. The research and development efforts of experts…….